Format

Send to

Choose Destination
Ther Adv Neurol Disord. 2017 Oct;10(10):339-341. doi: 10.1177/1756285617721093. Epub 2017 Jul 26.

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience.

Author information

1
Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Gudrunstr. 56, Bochum, D-44791, Germany.
2
Department of Hematology, Oncology and Palliative Care, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
3
Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center